Oman Technology Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oman Technology Reporter.

Press releases published on November 5, 2026

20 minutes ago

Alethio Therapeutics Raises $90 Million (£67 Million) in Oversubscribed Series A Financing to Advance a New Generation of Therapies for Myeloproliferative Neoplasms

Indeterminate GlobeNewswire

20 minutes ago

Einride and Lorenz Bring Autonomous Fleet to Production Facility in Germany

Indeterminate GlobeNewswire

20 minutes ago

Ethris Reports Positive Topline Phase 2a Data for Nasal mRNA Candidate ETH47 in Asthma Patients Challenged with Rhinovirus

Indeterminate GlobeNewswire

an hour ago

9M 2026: Novonesis delivered 7% organic sales growth, confirming full-year outlook

Indeterminate GlobeNewswire

an hour ago

T-Therapeutics announces oversubscribed $133 million Series B financing to achieve clinical proof-of-concept for first-in-class TCR bispecific therapies in cancer and autoimmune disease

Indeterminate GlobeNewswire

2 hours ago

ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business

Indeterminate GlobeNewswire

2 hours ago

WISeQey Advances PKI Modernization as Recent Cyberattacks Highlight the Need to Limit Identity and Credential Risks

Indeterminate GlobeNewswire

2 hours ago

Interim Report for Q3 2026

Indeterminate GlobeNewswire

4 hours ago

EZVIZ Launches November Deals in Mexico: Up to 15% Off Smart Locks and 4K Security Cameras

Indeterminate GlobeNewswire

6 hours ago

From Individual Upgrades to a Complete Workstation: Four Home Office Setup Ideas from Eureka Ergonomic

Indeterminate GlobeNewswire

6 hours ago

NEXSOLACE Presents SUPER GROOMER to Spotlight Professional Pet Grooming Talent

Indeterminate GlobeNewswire

6 hours ago

3D Systems Announces Agreements to Exchange All Outstanding 5.875% Convertible Senior Secured Notes Due 2030, Eliminating All Secured Debt

Indeterminate GlobeNewswire

7 hours ago

Cloudbreak Pharma Announces Top-Line Results from its Phase 3 Study of CBT-001 in Patients with Pterygium

Indeterminate GlobeNewswire

8 hours ago

Step Pharma to present data from ongoing phase 2 clinical trial of dencatistat in essential thrombocythaemia at 68th ASH Annual Meeting

Indeterminate GlobeNewswire

8 hours ago

Use Of Ryoncil First Line After Steroids For Pediatric Acute Graft Versus Host Disease Highlighted In Key Opinion Leader Webinar

Indeterminate GlobeNewswire

8 hours ago

HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Autoimmune Hemolytic Anemia

Indeterminate GlobeNewswire

8 hours ago

TaiMed Biologics to Present 24-Week Phase 2a Data on TMB-365/TMB-380 Maintenance Regimen at HIV Glasgow 2026

Indeterminate GlobeNewswire